Updated Jul 16, 2026
CAPELLO JEFFREY D has filed 2 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $100K.
Jeffrey D. Capello is a corporate director known for his roles at Neogen Corporation and Agios Pharmaceuticals, Inc. He has participated in various SEC filings related to these companies, primarily in a directorial capacity.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-23 | AGIO | AGIOS PHARMACEUTICALS, INC. | M — Option exercise | 2.8K | $0.00 | |
| 2026-06-16 | AGIO | AGIOS PHARMACEUTICALS, INC. | M — Option exercise | 2.0K | $0.00 | |
| 2025-10-07 | NEOG | NEOGEN CORP | M — Option exercise | 2.1K | $5.63 | $12K |
| 2025-06-18 | AGIO | AGIOS PHARMACEUTICALS, INC. | M — Option exercise | 2.1K | $0.00 | |
| 2025-06-13 | AGIO | AGIOS PHARMACEUTICALS, INC. | M — Option exercise | 2.0K | $0.00 | |
| 2025-04-22 | NEOG | NEOGEN CORP | P — Open-market purchase | 20.7K | $4.84 | $100K |
| 2024-10-29 | NEOG | NEOGEN CORP | M — Option exercise | 1.8K | $13.81 | $25K |
| 2024-10-28 | NEOG | NEOGEN CORP | A — Grant or award | 6.1K | $13.58 | $82K |
| 2024-10-09 | NEOG | NEOGEN CORP | M — Option exercise | 2.1K | $15.07 | $31K |
Jeffrey D. Capello is a corporate director known for his roles at Neogen Corporation and Agios Pharmaceuticals, Inc. He has participated in various SEC filings related to these companies, primarily in a directorial capacity.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($100K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live CAPELLO JEFFREY D profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.